This increase in Nanog and Oct4 expression was shown to be reversible by blocking IGF-II/IGF1R signaling, and similarly the increase in stem cell markers was not observed when lung cancer cells were co-cultured with normal fibroblasts. This evidence concerns the gene IGF2 and lung carcinoma.